close

Impact of Pharmacy in Research

Share this page
Link copied

Clinical academic pharmacists sit at the intersection of frontline healthcare and cutting-edge research, turning evidence into everyday practice.

This page highlights how their work transforms patient care, influences policy, drives service innovation, and shapes the future of pharmacy as a research-active profession.

Examples of impact

ActMed Study

Led in part by clinical academic pharmacist Dr Zoe Edwards, the ActMed study explored how patients and families access essential palliative medicines at home. The research uncovered delays and safety risks that could be reduced through stronger pharmacist involvement in hospice care. Its findings were cited in the House of Lords during the January 2020 second reading of the Access to Palliative Care Bill, demonstrating how clinical academic pharmacists can translate frontline research into national policy and safer, more responsive end-of-life care.

IMPACCT Study

This study examined how community pharmacists can improve the experience of people living with cancer. Dr  Zoe Edwards was a key researcher, showing how pharmacists help patients manage symptoms, navigate treatment and access timely support close to home. The findings influenced the Royal Pharmaceutical Society’s 2020 report, Utilising Community Pharmacists to Support People with Cancer, advocating for a more active pharmacy role in cancer care.

STOPP/START Criteria

Consensus-validated criteria for reviewing medicines in older adults established a practical, evidence-based approach to identifying inappropriate prescribing and missed treatments. Pharmacists’ involvement ensured the criteria were applicable in everyday practice, influencing national prescribing policy and guidance and improving safety for older patients across the NHS.

PINCER Study

This pharmacist-led, IT-supported intervention helped identify and reduce prescribing and monitoring errors in general practice. Combining computerised searches with pharmacist-delivered feedback, the study achieved meaningful reductions in hazardous prescribing and informed national medicines-optimisation policy, including adoption in NICE guidance.

Hadeel’s PhD explored how older people manage their medicines during the transition from hospital to home, a period linked to high risk of medication-related harm and avoidable readmissions.

MEDS-MADE study

Using a multi-method qualitative approach, including observations and interviews, Hadeel examined how older people manage medications in real-world settings. Grounded in behavioural science frameworks (COM-B and the Theoretical Domains Framework), the study looked at how individual, professional, and system-level factors influence safe medication use. It went beyond adherence to explore the behaviours, capabilities, opportunities, and motivations involved in medication self-management across care settings.

Key findings 

  • Identified gaps in how medication self-management is assessed
  • Developed behaviourally informed typologies describing diverse ways older people manage medicines
  • Co-designed the MedS-MB Toolkit prototype to support safer transitions from hospital to home
  • Highlighted the need for staff training to integrate medication self-management into discharge planning

Hadeel has shared her findings widely through conferences, webinars and workshops. She is now working with a national provider to translate her research into educational resources for NHS staff, with plans to further develop and evaluate the toolkit to inform service design, professional education and policy discussions aimed at improving patient safety.

Read Hadeel’s first PhD output: a systematic scoping review on measures and tools to assess medication self-management →

Neetu Bansal is a clinical academic pharmacist and Lecturer in Pharmacy Practice at the University of Manchester specialising in peri-operative medicines optimisation and post-surgical pain management. Her research focuses on improving the safety of opioid prescribing on transition from hospital to primary care, a period associated with increased risk of prolonged opioid use and medication-related harm.

Through an NIHR-funded Clinical Doctoral Research Fellowship, Neetu led the eTAPER study and examined the prevalence and risk factors for persistent post-operative opioid use using large-scale routine health data, alongside qualitative research with patients and healthcare professionals. This work highlighted how early discharge, limited follow-up, and fragmented care can contribute to ongoing opioid use after surgery.

Building on these findings, Neetu led the experience-based co-design of eTAPER, a digital, pharmacist-supported intervention to help patients safely taper opioids after surgery. Co-developed with patients and clinicians, and informed by behavioural science frameworks, eTAPER demonstrates how pharmacists can translate evidence into practical, patient-centred tools that support safer prescribing and continuity of care across healthcare settings.

Neetu’s work contributes to national discussions on opioid stewardship, peri-operative pain management, and the evolving role of pharmacists in surgical care pathways, illustrating the impact of research on patient safety. 

NIHR - What is a clinical trials pharmacist? Hear how Amber started her career in research

Explore further

Developing research skills

An inquisitive and curious mindset is fundamental to pursuing a clinical academic career. This should be supported by a broad...

Pharmacy technicians in clinical academia

Clinical academia combines clinical practice with research, education and innovation. For pharmacy technicians, it’s about using your practical experience to...
Last updated on 5 February 2026.